Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study

2009185 citationsJournal Article

Authors

Patients with relapsing multiple sclerosis randomized to interferon beta 1b or glatiramer acetate showed similar MRI and clinical activity.

Good health and well-being

Published in: Neurology

Volume 72, Issue 23, pp. 1976-1983

Field-Weighted Citation Impact: 16.78